OrthoPediatrics Q2 Adj EPS $(0.19), Inline, Sales $39.56M Beat $39.11M Estimate
Portfolio Pulse from totan@benzinga.com
OrthoPediatrics (NASDAQ:KIDS) reported Q2 losses of $(0.19) per share, meeting analyst consensus. This is a 11.76% decrease from last year. The company's quarterly sales of $39.56M beat the analyst consensus of $39.11M by 1.15%, marking a 20.14% increase from the same period last year.
July 31, 2023 | 8:26 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
OrthoPediatrics reported Q2 losses inline with estimates, but sales beat expectations and increased 20.14% YoY.
OrthoPediatrics' Q2 earnings were in line with analyst expectations, indicating stable performance. However, the company's sales exceeded estimates and showed significant YoY growth, which could potentially attract investor interest and offset the impact of the reported losses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100